Dr. Dayan Goodenowe Shifts Focus from Disease Treatment to Biological Resilience

Goodenowe’s shift in perspective originated from a realization during his early research: many biochemical markers once assumed to be consequences of disease were actually present in the body beforehand. This discovery pushed him to develop non-targeted metabolic profiling technology, a method capable of measuring thousands of molecules simultaneously to capture a holistic view of human metabolic activity.

His approach defines health not as the mere absence of pathology, but as the body’s active capacity to adapt and recover under pressure. This philosophy now anchors a newly approved long-term observational study across the United States and Canada. By tracking biological, functional, and quality-of-life metrics in real-world settings, the research seeks to map how health trajectories evolve over time. These findings form the core of his feature, 'The Science of Resilience,' which advocates for a fundamental redesign of how the medical community identifies and sustains wellness.